Pathstone Family Office LLC Acquires 9,449 Shares of Agilent Technologies, Inc. (NYSE:A)

Pathstone Family Office LLC lifted its stake in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 194.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 14,310 shares of the medical research company’s stock after acquiring an additional 9,449 shares during the quarter. Pathstone Family Office LLC’s holdings in Agilent Technologies were worth $1,600,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. BlackRock Inc. grew its stake in shares of Agilent Technologies by 1.1% during the 2nd quarter. BlackRock Inc. now owns 31,853,176 shares of the medical research company’s stock valued at $3,830,344,000 after acquiring an additional 349,651 shares during the period. Vanguard Group Inc. boosted its stake in Agilent Technologies by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock worth $3,246,209,000 after purchasing an additional 261,435 shares during the period. State Street Corp boosted its stake in Agilent Technologies by 2.0% in the 2nd quarter. State Street Corp now owns 13,214,595 shares of the medical research company’s stock worth $1,591,990,000 after purchasing an additional 253,729 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Agilent Technologies by 0.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 11,076,270 shares of the medical research company’s stock worth $1,238,549,000 after purchasing an additional 39,030 shares during the period. Finally, Geode Capital Management LLC boosted its stake in Agilent Technologies by 2.8% in the 2nd quarter. Geode Capital Management LLC now owns 6,378,218 shares of the medical research company’s stock worth $765,009,000 after purchasing an additional 174,439 shares during the period.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Philip Binns sold 2,880 shares of Agilent Technologies stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $139.78, for a total value of $402,566.40. Following the transaction, the senior vice president now owns 12,824 shares in the company, valued at $1,792,538.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Michael R. Mcmullen sold 62,467 shares of the business’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $130.00, for a total transaction of $8,120,710.00. Following the sale, the chief executive officer now owns 306,206 shares in the company, valued at $39,806,780. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Philip Binns sold 2,880 shares of the business’s stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $139.78, for a total value of $402,566.40. Following the sale, the senior vice president now owns 12,824 shares in the company, valued at approximately $1,792,538.72. The disclosure for this sale can be found here. Insiders have sold 95,929 shares of company stock worth $12,730,599 over the last quarter.

Analyst Upgrades and Downgrades

Several research firms have weighed in on A. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 19th. The Goldman Sachs Group increased their target price on Agilent Technologies from $128.00 to $145.00 and gave the company a “buy” rating in a research report on Thursday, December 7th. UBS Group downgraded Agilent Technologies from a “buy” rating to a “neutral” rating and lowered their target price for the company from $163.00 to $125.00 in a research report on Friday, November 17th. TheStreet upgraded Agilent Technologies from a “c+” rating to a “b-” rating in a research report on Friday, December 8th. Finally, Barclays increased their target price on Agilent Technologies from $100.00 to $120.00 and gave the company an “underweight” rating in a research report on Thursday, January 25th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $137.44.

Check Out Our Latest Stock Report on A

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $133.34 on Monday. The company has a current ratio of 2.61, a quick ratio of 1.97 and a debt-to-equity ratio of 0.47. The stock’s fifty day moving average price is $133.27 and its 200-day moving average price is $122.01. The firm has a market cap of $39.07 billion, a P/E ratio of 31.67, a P/E/G ratio of 3.04 and a beta of 1.11. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.75.

Agilent Technologies (NYSE:AGet Free Report) last released its quarterly earnings data on Monday, November 20th. The medical research company reported $1.38 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.04. The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 28.24% and a net margin of 18.15%. The firm’s quarterly revenue was down 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.53 earnings per share. On average, equities research analysts expect that Agilent Technologies, Inc. will post 5.48 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd were paid a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.71%. The ex-dividend date was Friday, December 29th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.23. Agilent Technologies’s payout ratio is 22.33%.

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.